Acuity (NYSE: AYI) director granted 546 restricted shares as fees
Rhea-AI Filing Summary
Acuity Inc. director James H. Hance Jr. reported receiving a restricted stock award of 546 shares of common stock on January 21, 2026. The shares were valued at $320.59 per share and were taken in lieu of a portion of his annual director fees, reflecting compensation paid in stock instead of cash.
After this grant, Hance directly beneficially owns 18,618 shares of Acuity Inc. common stock. The restricted stock will vest in full on the first anniversary of the grant date, or earlier if the next annual meeting of stockholders occurs before that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 546 | $320.59 | $175K |
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Acuity Inc. (AYI) disclose in this Form 4?
The filing shows that director James H. Hance Jr. received a restricted stock award of 546 shares of Acuity Inc. common stock on January 21, 2026 as part of his director compensation.
Why was the restricted stock award granted to the Acuity (AYI) director?
The restricted stock award (RSA) resulted from Hance's election to receive a portion of his annual director fees payable on January 21, 2026 in the form of an RSA instead of cash.
What are the vesting terms of the restricted stock awarded to the Acuity (AYI) director?
The RSA will vest in full on the first anniversary of the grant date, or, if earlier, on the date of the next subsequent annual meeting of Acuity Inc.'s stockholders following the grant date.
Is this Acuity (AYI) Form 4 transaction a purchase on the open market?
No. The filing describes the transaction as a restricted stock award issued under Acuity Inc.'s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan, tied to director fees, not an open-market trade.